157 related articles for article (PubMed ID: 25880253)
21. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
22. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
23. Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Stacchiotti S; Pantaleo MA; Astolfi A; Dagrada GP; Negri T; Dei Tos AP; Indio V; Morosi C; Gronchi A; Colombo C; Conca E; Toffolatti L; Tazzari M; Crippa F; Maestro R; Pilotti S; Casali PG
Eur J Cancer; 2014 Jun; 50(9):1657-64. PubMed ID: 24703573
[TBL] [Abstract][Full Text] [Related]
24. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.
Segal NH; Pavlidis P; Noble WS; Antonescu CR; Viale A; Wesley UV; Busam K; Gallardo H; DeSantis D; Brennan MF; Cordon-Cardo C; Wolchok JD; Houghton AN
J Clin Oncol; 2003 May; 21(9):1775-81. PubMed ID: 12721254
[TBL] [Abstract][Full Text] [Related]
25. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract][Full Text] [Related]
26. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
Li KK; Lee KA
Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.
Mackensen A; Meidenbauer N; Vogl S; Laumer M; Berger J; Andreesen R
J Clin Oncol; 2006 Nov; 24(31):5060-9. PubMed ID: 17075125
[TBL] [Abstract][Full Text] [Related]
28. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
29. Cytomorphological spectrum, including immunohistochemical results of 16 cases of clear cell sarcoma of soft tissue, along with positive EWSR1 gene rearrangement result in two cases.
Rao V; Rekhi B
Cytopathology; 2020 Jul; 31(4):280-287. PubMed ID: 32356379
[TBL] [Abstract][Full Text] [Related]
30. A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.
Nakayama S; Yokote T; Iwaki K; Akioka T; Miyoshi T; Hirata Y; Takayama A; Nishiwaki U; Masuda Y; Tsuji M; Hanafusa T
BMC Cancer; 2012 Nov; 12():538. PubMed ID: 23170958
[TBL] [Abstract][Full Text] [Related]
31. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
[TBL] [Abstract][Full Text] [Related]
32. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
Komura S; Ito K; Ohta S; Ukai T; Kabata M; Itakura F; Semi K; Matsuda Y; Hashimoto K; Shibata H; Sone M; Jo N; Sekiguchi K; Ohno T; Akiyama H; Shimizu K; Woltjen K; Ozawa M; Toguchida J; Yamamoto T; Yamada Y
Nat Commun; 2019 Sep; 10(1):3999. PubMed ID: 31488818
[TBL] [Abstract][Full Text] [Related]
33. Absence of 19 known hotspot oncogenic mutations in soft tissue clear cell sarcoma: two cases report with review of the literature.
Liu C; Ren Y; Li X; Cao Y; Chen Y; Cui X; Li L; Li F
Int J Clin Exp Pathol; 2014; 7(8):5242-9. PubMed ID: 25197404
[TBL] [Abstract][Full Text] [Related]
34. Biology and management of clear cell sarcoma: state of the art and future perspectives.
Cornillie J; van Cann T; Wozniak A; Hompes D; Schöffski P
Expert Rev Anticancer Ther; 2016 Aug; 16(8):839-45. PubMed ID: 27253849
[TBL] [Abstract][Full Text] [Related]
35. Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).
Jakob J; Simeonova A; Kasper B; Ronellenfitsch U; Rauch G; Wenz F; Hohenberger P
Radiat Oncol; 2016 Jun; 11():77. PubMed ID: 27255678
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
Lyle PL; Amato CM; Fitzpatrick JE; Robinson WA
Am J Surg Pathol; 2008 Jun; 32(6):858-66. PubMed ID: 18408594
[TBL] [Abstract][Full Text] [Related]
37. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
[TBL] [Abstract][Full Text] [Related]
38. Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.
Khammari A; Labarrière N; Vignard V; Nguyen JM; Pandolfino MC; Knol AC; Quéreux G; Saiagh S; Brocard A; Jotereau F; Dreno B
J Invest Dermatol; 2009 Dec; 129(12):2835-42. PubMed ID: 19554023
[TBL] [Abstract][Full Text] [Related]
39. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
Di Pucchio T; Pilla L; Capone I; Ferrantini M; Montefiore E; Urbani F; Patuzzo R; Pennacchioli E; Santinami M; Cova A; Sovena G; Arienti F; Lombardo C; Lombardi A; Caporaso P; D'Atri S; Marchetti P; Bonmassar E; Parmiani G; Belardelli F; Rivoltini L
Cancer Res; 2006 May; 66(9):4943-51. PubMed ID: 16651452
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
